LEMAITRE VASCULAR, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
LEMAITRE VASCULAR, INC. (LMAT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $8.36 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-02-26
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $8.36M, a 14.96% increase from fiscal 2024.
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $7.27M, a 22.95% increase from fiscal 2023.
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $5.91M, a 95.76% increase from fiscal 2022.
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $3.02M, a 0.00% change from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 24 month |
|---|---|---|---|
| 2025-12-31 | $8.36M 10-K · filed 2026-02-26 | ||
| 2024-12-31 | $7.27M 10-K · filed 2026-02-26 | ||
| 2023-12-31 | $5.91M 10-K · filed 2026-02-26 | ||
| 2022-12-31 | $3.02M 10-K · filed 2025-02-28 | ||
| 2021-12-31 | $3.02M 10-K · filed 2024-02-29 | $6.97M 10-K · filed 2022-02-28 | |
| 2020-12-31 | $6.97M 10-K · filed 2024-02-29 | $5.41M 10-K · filed 2022-02-28 | $5.41M 10-K · filed 2021-03-12 |
| 2019-12-31 | $11.49M 10-K · filed 2022-02-28 | $11.49M 10-K · filed 2020-03-12 | |
| 2018-12-31 | $7.20M 10-K · filed 2019-03-11 | ||
| 2017-12-31 | $13.09M 10-K · filed 2018-03-09 | ||
| 2016-12-31 | $2.39M 10-K · filed 2018-03-09 | ||
| 2015-12-31 | $6.53M 10-K · filed 2018-03-09 | ||
| 2014-12-31 | $819.48K 10-K · filed 2017-03-09 | ||
| 2013-12-31 | $1.01M 10-K · filed 2016-03-10 | ||
| 2012-12-31 | $340.68K 10-K · filed 2015-03-18 | $340.68M 10-K · filed 2013-03-27 | |
| 2011-12-31 | $321.58K 10-K · filed 2014-03-21 | $321.58M 10-K · filed 2013-03-27 | |
| 2010-12-31 | $343.19M 10-K · filed 2013-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |